HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Yuan Selected Research

Interleukin-17 (Interleukin 17)

2/2023Peptide-Protected Gold Nanoclusters Efficiently Ameliorate Acute Contact Dermatitis and Psoriasis via Repressing the TNF-α/NF-κB/IL-17A Axis in Keratinocytes.
10/2022EphA2 recognizes Dermatophagoidespteronyssinus to mediate airway inflammation in asthma.
5/2022Changes in the phenotype and function of mucosal-associated invariant T cells in neutrophilic asthma.
8/2020[Establishment of a mouse neutrophil-dominated house dust mite allergic asthma model].
1/2017IL-17C/IL-17RE Augments T Cell Function in Autoimmune Hepatitis.
1/2013Interferon regulatory factor 3 deficiency leads to interleukin-17-mediated liver ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Yuan Research Topics

Disease

87Neoplasms (Cancer)
04/2024 - 03/2008
30Inflammation (Inflammations)
03/2024 - 01/2013
18Neoplasm Metastasis (Metastasis)
01/2023 - 01/2015
11Infections
10/2023 - 02/2016
10Lung Neoplasms (Lung Cancer)
01/2023 - 10/2017
9Hepatocellular Carcinoma (Hepatoma)
03/2021 - 10/2011
8Renal Cell Carcinoma (Grawitz Tumor)
07/2022 - 08/2017
8Breast Neoplasms (Breast Cancer)
02/2022 - 01/2014
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 07/2014
7Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 01/2019
6Hypoxia (Hypoxemia)
05/2023 - 12/2012
6Asthma (Bronchial Asthma)
10/2022 - 06/2012
6Reperfusion Injury
09/2022 - 01/2011
5Autistic Disorder (Autism)
02/2022 - 05/2006
4Prostatic Neoplasms (Prostate Cancer)
02/2024 - 09/2011
4Glioma (Gliomas)
05/2023 - 09/2020
4Sepsis (Septicemia)
01/2023 - 04/2020
4Carcinogenesis
01/2023 - 10/2011
4Brain Neoplasms (Brain Tumor)
01/2023 - 01/2022
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
10/2022 - 05/2017
4Carcinoma (Carcinomatosis)
08/2022 - 10/2011
4Adenocarcinoma of Lung
01/2022 - 01/2020
3Ovarian Neoplasms (Ovarian Cancer)
05/2024 - 01/2023
3Lung Injury
11/2023 - 01/2014
3Wounds and Injuries (Trauma)
06/2022 - 11/2018
3Rheumatoid Arthritis
06/2022 - 08/2019
3COVID-19
06/2022 - 01/2021
3Liver Neoplasms (Liver Cancer)
01/2022 - 08/2015
3Ischemia
01/2022 - 01/2011
3Brain Ischemia (Cerebral Ischemia)
01/2022 - 05/2017
3Neuroinflammatory Diseases
01/2021 - 01/2019
3Body Weight (Weight, Body)
05/2019 - 05/2011
3Burns
11/2018 - 07/2018
3Fibrosis (Cirrhosis)
05/2015 - 10/2011
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2024 - 01/2022
2Trigeminal Neuralgia (Tic Douloureux)
03/2024 - 01/2019
2Esophageal Squamous Cell Carcinoma
02/2024 - 04/2022

Drug/Important Bio-Agent (IBA)

27Biomarkers (Surrogate Marker)IBA
05/2024 - 12/2012
26Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2011
15GoldIBA
01/2024 - 11/2015
13CytokinesIBA
05/2023 - 01/2011
10Mitochondrial DNA (mtDNA)IBA
01/2024 - 01/2021
10Peptides (Polypeptides)IBA
02/2023 - 11/2015
9Therapeutic UsesIBA
10/2022 - 03/2006
8Messenger RNA (mRNA)IBA
04/2023 - 10/2011
8RNA (Ribonucleic Acid)IBA
03/2023 - 02/2015
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 03/2010
6AntigensIBA
03/2024 - 08/2015
6Interleukin-17 (Interleukin 17)IBA
02/2023 - 01/2013
6Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021 - 01/2011
5Interleukin-8 (Interleukin 8)IBA
01/2023 - 01/2014
5Interleukin-6 (Interleukin 6)IBA
10/2022 - 08/2020
4LipopolysaccharidesIBA
05/2024 - 09/2014
4AntibodiesIBA
03/2024 - 01/2016
4VancomycinFDA LinkGeneric
10/2023 - 11/2018
4isovitexinIBA
08/2022 - 06/2019
4EnzymesIBA
01/2022 - 11/2015
4Transcription Factors (Transcription Factor)IBA
01/2022 - 01/2013
4LipidsIBA
01/2021 - 11/2016
4Superoxide DismutaseIBA
01/2021 - 06/2018
4Glutathione (Reduced Glutathione)IBA
01/2020 - 01/2017
4Ophthalmic Solutions (Eye Drops)IBA
11/2018 - 01/2017
3InflammasomesIBA
03/2024 - 01/2021
3NucleotidesIBA
03/2024 - 01/2021
3Hormones (Hormone)IBA
05/2023 - 01/2014
3IronIBA
02/2023 - 09/2015
3salicylhydroxamic acid (SHAM)IBA
10/2022 - 12/2014
3Neuroprotective AgentsIBA
01/2022 - 05/2017
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2017
3salvianolateIBA
01/2022 - 05/2017
3Indicators and Reagents (Reagents)IBA
01/2022 - 01/2020
3MetalsIBA
10/2021 - 01/2021
3Tumor Biomarkers (Tumor Markers)IBA
03/2021 - 01/2020
3IntegrinsIBA
12/2018 - 11/2015
3Matrix Metalloproteinase 14 (MT1-MMP)IBA
11/2018 - 01/2018
3AlkaliesIBA
11/2018 - 07/2018
3Glucose (Dextrose)FDA LinkGeneric
10/2017 - 02/2016
3Oxygen (Dioxygen)IBA
08/2017 - 12/2012
3AntioxidantsIBA
04/2017 - 10/2014
3Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
09/2014 - 05/2011
2Lipid NanoparticlesIBA
05/2024 - 01/2014
2SuspensionsIBA
04/2024 - 06/2018
2Advanced Glycation End ProductsIBA
03/2024 - 01/2019
2Protease Inhibitors (Protease Inhibitor)IBA
02/2024 - 12/2021
2Contrast MediaIBA
02/2024 - 07/2018

Therapy/Procedure

39Therapeutics
02/2024 - 09/2002
7Drug Therapy (Chemotherapy)
11/2023 - 10/2014
6Immunotherapy
05/2023 - 11/2019
5Radiotherapy
01/2023 - 06/2016
5Percutaneous Collagen Induction
03/2017 - 05/2006
4Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 09/2009
4Kidney Transplantation
01/2022 - 01/2020
3Aftercare (After-Treatment)
03/2024 - 05/2006
3Nephrectomy
09/2022 - 02/2018
3Transplantation
01/2022 - 01/2021
3Intraperitoneal Injections
01/2022 - 03/2008
3Liver Transplantation
12/2021 - 08/2017
3Acupuncture Points (Acupuncture Point)
02/2021 - 07/2019
3Acupuncture Therapy
07/2013 - 03/2006
2Art Therapy
02/2024 - 01/2020